Tags & Categorías

Genentech and Pfizer Reach Settlement Over Biosimilar Trastuzumab

Recently, plaintiff Genentech and defendant Pfizer filed a collective stipulation and proposed order of dismissal of a patent infringement lawsuit ove...

BioSim y Sedisa crean un marco de colaboración para promover los biosimilares

Con este acuerdo, BioSim y Sedisa quieren desarrollar programas de formación, difusión y realización de estudios en biosimilares.

La OCDE subraya la baja tasa de penetración del biosimilar en Europa

La Organización para la Cooperación y el Desarrollo Económicos concluye que Alemania es el único país con todos los biosimilares aprobados y fina...

La revolución de los biosimilares

Artículo de opinión de Miguel Ángel Calleja, presidente de la Sociedad Española de Farmacia Hospitalaria (SEFH).

Pfizer Becomes Latest to Settle With AbbVie Over Humira

On Friday, Pfizer announced that it has signed an agreement with AbbVie that resolves all intellectual property disputes related to Pfizer’s PF-0641...

Kern incorpora a hematólogos en la 3ª edición de su ‘Experto en BiosimilaresÂ’

Kern Pharma ha celebrado la reunión presencial y la entrega de diplomas de la tercera edición del Título de Experto Universitario en Biosimilares e...

Boehringer Ingelheim to Pull Out of EU Biosimilars Market, Focus on US

Earlier this week, Bioprocess International reported that Boehringer Ingelheim (BI) had decided to focus on launching its biosimilar products solely...

European Report Finds Generics and Biosimilars Key to Curbing Wasteful Drug Spending

The European Commission, in conjunction with the Organization for Economic Co-operation and Development, has released its Health at a Glance: Europe 2...

European Commission approves MundipharmaÂ’s pegfilgrastim biosimilar Pelmeg

The Mundipharma network of independent associated companies  announced that the European Commission (EC) has granted approval for the use of Pelmeg (...

Sandoz Gains European Authorization for Pegfilgrastim Biosimilar, Ziextenzo

Sandoz announced today that the European Commission has granted a marketing authorization for its pegfilgrastim biosimilar, Ziextenzo, referencing Neu...